Bahrain Mumtalakat Holding Company (Mumtalakat), the sovereign wealth fund of the Kingdom of Bahrain, has announced
Explore MoreM42, a leading global health-tech powerhouse, is proud to unveil its lineup of top global health experts to convene on the M42 Main Stage at the inaugural Abu Dhabi Global Healthcare Week 2024 (ADGHW).
Explore MoreM42, a first-of-its-kind tech-enabled global health powerhouse, has signed a groundbreaking agreement with AstraZeneca, a global leader in science-led biopharmaceuticals, to advance preventive healthcare and next-generation precision medicine.
Explore MoreM42, committed to supporting women’s health, launces new corporate policies to promote gender equity and sets the benchmark for best practices globally
Explore MoreThis work sets the foundation for the transformation of clinico-genomic data access, data science and international genomic research.
Explore MoreM42 is empowering sustainable global health through tech solutions including genomics
Explore MoreDiaverum has been at the forefront of transforming renal care in the Kingdom for over a decade
The holistic program underscores commitment to cancer awareness, prevention and treatment across facilities
CHSC’s can perform 2,000 daily AI X-rays is a 10-fold increase on conventional methods, transforming tuberculosis (TB) detection...
The United Arab Emirates (UAE) has emerged as a global hub for business and innovation, drawing talent from across the world. As...
As part of its commitment to maximizing the positive impact of genomics on health, M42, a tech-enabled global health powerhouse,...
Treatment is available for a wide range of conditions including traumas, tumors, reconstruction, care and rehabilitation